BA
KYTH

BlackRock Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

BlackRock Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-35,073
Closed -$2.63M – 3908
2015
Q3 		$2.63M Buy
35,073
+1,984
+6% +$148K ﹤0.01% 1278
2015
Q2 		$2.49M Buy
33,089
+21,577
+187% +$1.16M ﹤0.01% 1182
2015
Q1 		$577K Buy
11,512
+2,586
+29% +$109K ﹤0.01% 1977
2014
Q4 		$310K Sell
8,926
-386
-4% -$13.5K ﹤0.01% 2342
2014
Q3 		$305K Buy
9,312
+1,959
+27% +$69K ﹤0.01% 2337
2014
Q2 		$282K Buy
7,353
+1,202
+20% +$42K ﹤0.01% 2423
2014
Q1 		$245K Buy
6,151
+292
+5% +$13.1K ﹤0.01% 2525
2013
Q4 		$219K Buy
5,859
+1,183
+25% +$49.1K ﹤0.01% 2605
2013
Q3 		$213K Buy
4,676
+24
+0.5% +$718 ﹤0.01% 2519
2013
Q2 		$126K Buy
+4,652
New +$106K ﹤0.01% 2751

BlackRock Advisors's KYTH Position: Q4 2015 in Review

BlackRock Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 35,073 shares — an estimated $2.63M sold.

BlackRock Advisors first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $2.63M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • BlackRock Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • BlackRock Advisors sold 35,073 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $2.63M.
  • BlackRock Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • BlackRock Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.63M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on BlackRock Advisors's 13F filing for Q4 2015, filed 11 Feb 2016.